Related Experiment Video
Updated: Oct 10, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBP
Abstract:
Adenovirus E1A mediates its effects on cellular transformation and transcription by interacting with critical cellular proteins involved in cell growth and differentiation. The amino terminus of E1A binds to CBP/p300 and associated histone acetyltransferases such as P/CAF. The carboxyl terminus binds to the carboxyl-terminal binding protein (CtBP), which associates with histone deacetylases. We show that 12S E1A can be acetylated by p300 and P/CAF and map one of the acetylation sites to Lys-239. This Lys residue is adjacent to the consensus CtBP binding motif, PXDLS. Mutation of Lys-239 to Gln or Ala blocks CtBP binding in vitro and disrupts the E1A-CtBP interaction in vivo. Peptide competition assays demonstrated that the interaction of E1A with CtBP is also blocked by Lys-239 acetylation. Supporting a functional role for Lys-239 in CtBP binding, mutation of this residue to Ala decreases the ability of E1A to block cAMP-regulated enhancer (CRE)-binding protein (CREB)-stimulated gene expression. Finally, we demonstrate that Lys-239 is acetylated in cells by using an antibody directed against an acetyl-Lys-239 E1A peptide. CtBP interacts with a wide variety of other transcriptional repressors through the PXDLS motif, and, in many instances, this motif is followed by a Lys residue. We suggest that acetylation of this residue by histone acetyltransferases, and the consequent disruption of repressor complexes, might be a general mechanism for gene activation.
Insights
Adenovirus E1A protein acetylation, specifically at Lys-239, disrupts its binding to CtBP. This acetylation by histone acetyltransferases may be a general mechanism for gene activation by releasing repressor complexes.
Area of Science:
- Molecular Biology
- Virology
- Epigenetics
Background:
- Adenovirus E1A protein regulates cellular processes by interacting with key cellular proteins.
- E1A's N-terminus binds CBP/p300 and histone acetyltransferases, while its C-terminus binds CtBP, a protein associated with histone deacetylases.
Purpose of the Study:
- To investigate the role of E1A acetylation in its interaction with CtBP.
- To identify specific acetylation sites on E1A and their functional consequences.
Main Methods:
- In vitro and in vivo binding assays to study E1A-CtBP interactions.
- Site-directed mutagenesis to alter Lys-239 residue on E1A.
- Peptide competition assays and reporter gene assays to assess functional impact.
- Development of an antibody specific for acetylated Lys-239 E1A.
Main Results:
- 12S E1A can be acetylated by p300 and P/CAF, with Lys-239 identified as an acetylation site.
- Mutation of Lys-239 to Gln or Ala abolished CtBP binding in vitro and disrupted the E1A-CtBP interaction in vivo.
- Acetylation of Lys-239 blocked E1A-CtBP interaction, and mutation of Lys-239 decreased E1A's ability to inhibit CREB-stimulated gene expression.
- Lys-239 acetylation was confirmed in cells using a specific antibody.
Conclusions:
- Acetylation of Adenovirus E1A at Lys-239 is a critical regulatory mechanism that disrupts its interaction with CtBP.
- This acetylation event, mediated by histone acetyltransferases, may represent a general strategy for transcriptional activation by releasing repressor complexes.
- The findings provide insights into the epigenetic regulation of viral gene expression and cellular transformation.
Related Concept Videos
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

